This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IsoRay To Demonstrate GliaSite At Annual Meeting Of American Association Of Neurological Surgeons

IsoRay, Inc. (AMEX: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth at the 80th Annual Meeting of the American Association of Neurological Surgeons (AANS). The annual meeting will take place April 14-18, 2012 in Miami Beach, Florida at the Miami Beach Convention Center.

IsoRay’s participation marks the Company's formal introduction to the neuroscience community. At IsoRay’s booth (Booth 952), a series of discussion groups and presentations will be taking place led by a number of thought leaders from major medical centers. In addition to demonstrating the GliaSite® radiation system, the booth will also feature slide shows, videos, and working demonstrations of the application of mesh with embedded seeds.

IsoRay has exclusive worldwide distribution rights for the GliaSite® radiation therapy system. GliaSite® is an innovative, significant advance over previous brain cancer treatments. Doctors are able to use the system to directly place a specified dosage of liquid radiation in areas where cancer is most likely to still remain after completion of surgical brain tumor removal. The ability to precisely place a specified dosage of this form of radiation means there is less likelihood for damage to occur to healthy brain tissue compared to other alternative treatments. Importantly, the GliaSite® radiation treatment impacts the ability of the tumor to recur which means crucial benefits for patients in longevity as well as quality of life.

In another key development, yet another leading institution has adopted the GliaSite® radiation therapy system. The University of Maryland has just completed its first treatment of a brain cancer patient using GliaSite®. According to IsoRay CEO Dwight Babcock some 65,000 new cases of primary brain tumors are expected to be diagnosed this year amongst all age groups. "Brain cancer doesn't discriminate. It afflicts men, women, and children with devastating impact. GliaSite® is showing dramatic results in treating a variety of brain cancers and we are confident that physicians will quickly adopt this vital treatment."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs